Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Aktuell 19 mai 2023 Helisul kauft Jedsy-Drohnen für bis zu 26 Millionen Dollar Die brasilianische Helisul Aviação will sich in ihrem Land mithilfe der Gleiter und Andockstationen des St.Galler Unternehmens Jedsy als führende...
成功談 12 dez 2023 「最初の選択肢はスイスでしたし、これからもスイスであり続けます」 M&K Global AGはドローンサービスの統合戦略、実社会への導入、教育に注力する、ベルンを拠点とするホールディングカンパニーです。M&K Global AGはスイスで3年半の間に、1人体制だった運営から18人の組織に成長を遂げました。
News 09 abr 2024 DESI project unveils groundbreaking 3D universe map with EPFL’s aid EPFL astrophysicists have contributed to creating the most detailed 3D map of the universe, tracing expansion over 11 billion years.
News 12 out 2023 Jedsy enters into multi-million dollar contract with Asklepios Drone manufacturer Jedsy, based in the St.GallenBodenseeArea, has entered into a large delivery contract with German hospital group Asklepios. Th...
成功故事 12 dez 2023 “无论是过去或未来,我们的首选永远是瑞士" M&K Global AG 是一家总部位于瑞士首都伯尔尼的控股公司,专注于无人机服务集成、现实世界行业应用和相关教育战略。瑞士的 M&K Global AG 在 3 年半的时间里,从一个人运营成长为18人的组织。
News 19 mai 2023 Helisul buys Jedsy drones for up to $26 million Brazilian company Helisul Aviação is seeking to establish itself as a leading provider of drone delivery services in Brazil, with the help of gli...
News 13 mar 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Actualités 12 jan 2022 ObsEva obtient des résultats positifs dans le traitement de l’endométriose Spécialisée dans la santé des femmes, la société biopharmaceutique genevoise ObsEva a annoncé des résultats préliminaires positifs de l'essai de ...
News 14 fev 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
Aktuell 10 out 2023 MSD bekennt sich zum Standort Luzern MSD Schweiz will von Luzern aus weiter wachsen. Seit seiner Gründung vor 60 Jahren hat das Pharmaunternehmen kantonsweit eine halbe Milliarde Fr...
News 12 jan 2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...
News 15 ago 2023 SAEKI Robotics secures investment of 2.3 million US dollars SAEKI Robotics has secured investment of 2.3 million US dollars as part of a seed funding round. The fresh capital will be put towards building a...